
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10831629
[patent_doc_number] => 08859798
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Isothiocyanate compounds, pharmaceutical compositions, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/307724
[patent_app_country] => US
[patent_app_date] => 2007-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 30115
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12307724
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/307724 | Isothiocyanate compounds, pharmaceutical compositions, and uses thereof | Jul 5, 2007 | Issued |
Array
(
[id] => 8571951
[patent_doc_number] => 08338599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Compounds having a potentiating effect on the activity of ethionamide and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/306333
[patent_app_country] => US
[patent_app_date] => 2007-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26903
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12306333
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/306333 | Compounds having a potentiating effect on the activity of ethionamide and uses thereof | Jul 3, 2007 | Issued |
Array
(
[id] => 6251632
[patent_doc_number] => 20100028274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT'
[patent_app_type] => utility
[patent_app_number] => 12/519585
[patent_app_country] => US
[patent_app_date] => 2007-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8126
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028274.pdf
[firstpage_image] =>[orig_patent_app_number] => 12519585
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/519585 | ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT | Jun 27, 2007 | Abandoned |
Array
(
[id] => 5297242
[patent_doc_number] => 20090012168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'ADIPONECTION INDUCERS OR SECRETAGOGUES'
[patent_app_type] => utility
[patent_app_number] => 11/770121
[patent_app_country] => US
[patent_app_date] => 2007-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4833
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012168.pdf
[firstpage_image] =>[orig_patent_app_number] => 11770121
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/770121 | ADIPONECTION INDUCERS OR SECRETAGOGUES | Jun 27, 2007 | Abandoned |
Array
(
[id] => 4693144
[patent_doc_number] => 20080085915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'COMPOUNDS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/765554
[patent_app_country] => US
[patent_app_date] => 2007-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21167
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20080085915.pdf
[firstpage_image] =>[orig_patent_app_number] => 11765554
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/765554 | COMPOUNDS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS | Jun 19, 2007 | Abandoned |
Array
(
[id] => 4916317
[patent_doc_number] => 20080096918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'NOVEL CYCLIC UREAS USED AS INHIBITORS OF METALLOPROTEASES'
[patent_app_type] => utility
[patent_app_number] => 11/763618
[patent_app_country] => US
[patent_app_date] => 2007-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16152
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096918.pdf
[firstpage_image] =>[orig_patent_app_number] => 11763618
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/763618 | Cyclic ureas used as inhibitors of metalloproteases | Jun 14, 2007 | Issued |
Array
(
[id] => 5126520
[patent_doc_number] => 20070238791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators'
[patent_app_type] => utility
[patent_app_number] => 11/818139
[patent_app_country] => US
[patent_app_date] => 2007-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6214
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238791.pdf
[firstpage_image] =>[orig_patent_app_number] => 11818139
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/818139 | Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators | Jun 11, 2007 | Abandoned |
Array
(
[id] => 4670524
[patent_doc_number] => 20080045584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Use of Docetaxel for Treating Hepatocellular Carcinoma'
[patent_app_type] => utility
[patent_app_number] => 11/761512
[patent_app_country] => US
[patent_app_date] => 2007-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3780
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045584.pdf
[firstpage_image] =>[orig_patent_app_number] => 11761512
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/761512 | Use of Docetaxel for Treating Hepatocellular Carcinoma | Jun 11, 2007 | Abandoned |
Array
(
[id] => 204863
[patent_doc_number] => 07629365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-08
[patent_title] => 'Heterocyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/755849
[patent_app_country] => US
[patent_app_date] => 2007-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18983
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/629/07629365.pdf
[firstpage_image] =>[orig_patent_app_number] => 11755849
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/755849 | Heterocyclic compounds | May 30, 2007 | Issued |
Array
(
[id] => 9524231
[patent_doc_number] => 08748497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => 'Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses'
[patent_app_type] => utility
[patent_app_number] => 12/227502
[patent_app_country] => US
[patent_app_date] => 2007-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 23062
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12227502
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/227502 | Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses | May 21, 2007 | Issued |
Array
(
[id] => 6249493
[patent_doc_number] => 20100137437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => ' Composition for Inactivating an Enveloped Virus'
[patent_app_type] => utility
[patent_app_number] => 12/301381
[patent_app_country] => US
[patent_app_date] => 2007-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8083
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137437.pdf
[firstpage_image] =>[orig_patent_app_number] => 12301381
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/301381 | Composition for inactivating an enveloped virus | May 17, 2007 | Issued |
Array
(
[id] => 4779542
[patent_doc_number] => 20080287540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'LIP CARE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/749797
[patent_app_country] => US
[patent_app_date] => 2007-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3228
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287540.pdf
[firstpage_image] =>[orig_patent_app_number] => 11749797
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/749797 | LIP CARE COMPOSITIONS | May 16, 2007 | Abandoned |
Array
(
[id] => 5027945
[patent_doc_number] => 20070269392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Personal care compositions'
[patent_app_type] => utility
[patent_app_number] => 11/801872
[patent_app_country] => US
[patent_app_date] => 2007-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14096
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269392.pdf
[firstpage_image] =>[orig_patent_app_number] => 11801872
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/801872 | Personal care compositions | May 10, 2007 | Issued |
Array
(
[id] => 5398316
[patent_doc_number] => 20090318379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Statins for the Treatment of Viral Influenza Infections'
[patent_app_type] => utility
[patent_app_number] => 12/226960
[patent_app_country] => US
[patent_app_date] => 2007-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6428
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318379.pdf
[firstpage_image] =>[orig_patent_app_number] => 12226960
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/226960 | Statins for the Treatment of Viral Influenza Infections | May 3, 2007 | Abandoned |
Array
(
[id] => 5131609
[patent_doc_number] => 20070208006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'DERIVATIVES OF N-[PHENYL(PYRROLIDINE-2-YL)METHYL]BENZAMIDE AND N-[(AZEPAN-2-YL)PHENYLMETHYL]BENZAMIDE, PREPARATION METHOD THEREOF AND APPLICATION OF SAME IN THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 11/741803
[patent_app_country] => US
[patent_app_date] => 2007-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7349
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20070208006.pdf
[firstpage_image] =>[orig_patent_app_number] => 11741803
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/741803 | Derivatives of N-[phenyl(pyrrolidine-2-YL)methyl]benzamide and N-[(azepan-2-YL) phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics | Apr 29, 2007 | Issued |
Array
(
[id] => 4860488
[patent_doc_number] => 20080269338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'AQUEOUS SOLUTIONS CONTAINING CHLORAMINE WHICH ARE FREE FROM DI-AND TRICHLOROAMINE, AS WELL AS FROM AMMONIA'
[patent_app_type] => utility
[patent_app_number] => 11/742303
[patent_app_country] => US
[patent_app_date] => 2007-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3796
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269338.pdf
[firstpage_image] =>[orig_patent_app_number] => 11742303
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/742303 | AQUEOUS SOLUTIONS CONTAINING CHLORAMINE WHICH ARE FREE FROM DI-AND TRICHLOROAMINE, AS WELL AS FROM AMMONIA | Apr 29, 2007 | Abandoned |
Array
(
[id] => 5539842
[patent_doc_number] => 20090221647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'N-(2-THIAZOLYL)-AMIDE DERIVATIVES AS GSK-3 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/298861
[patent_app_country] => US
[patent_app_date] => 2007-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6146
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221647.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298861
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298861 | N-(2-THIAZOLYL)-AMIDE DERIVATIVES AS GSK-3 INHIBITORS | Apr 26, 2007 | Abandoned |
Array
(
[id] => 7682240
[patent_doc_number] => 20100022568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'ENDOTHELIN RECEPTOR ANTAGONISTS FOR EARLY STAGE IDIOPATHIC PULMONARY FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/296895
[patent_app_country] => US
[patent_app_date] => 2007-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10832
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022568.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296895
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296895 | ENDOTHELIN RECEPTOR ANTAGONISTS FOR EARLY STAGE IDIOPATHIC PULMONARY FIBROSIS | Apr 11, 2007 | Abandoned |
Array
(
[id] => 4718719
[patent_doc_number] => 20080241241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'MINOCYCLINE ORAL DOSAGE FORMS FOR THE TREATMENT OF ACNE'
[patent_app_type] => utility
[patent_app_number] => 11/695513
[patent_app_country] => US
[patent_app_date] => 2007-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 40319
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241241.pdf
[firstpage_image] =>[orig_patent_app_number] => 11695513
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/695513 | Minocycline oral dosage forms for the treatment of acne | Apr 1, 2007 | Issued |
Array
(
[id] => 4720119
[patent_doc_number] => 20080242642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'MINOCYCLINE ORAL DOSAGE FORMS FOR THE TREATMENT OF ACNE'
[patent_app_type] => utility
[patent_app_number] => 11/695541
[patent_app_country] => US
[patent_app_date] => 2007-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 40294
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242642.pdf
[firstpage_image] =>[orig_patent_app_number] => 11695541
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/695541 | MINOCYCLINE ORAL DOSAGE FORMS FOR THE TREATMENT OF ACNE | Apr 1, 2007 | Abandoned |